Follow
Kei Suzuki
Kei Suzuki
Boston University School of Medicine
Verified email at bmc.org
Title
Cited by
Cited by
Year
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
4422020
Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent …
K Suzuki, K Kadota, CS Sima, J Nitadori, VW Rusch, WD Travis, ...
Journal of clinical oncology 31 (4), 490, 2013
2022013
Prognostic immune markers in non–small cell lung cancer
K Suzuki, SS Kachala, K Kadota, R Shen, Q Mo, DG Beer, VW Rusch, ...
Clinical Cancer Research 17 (16), 5247-5256, 2011
1902011
A proteogenomic portrait of lung squamous cell carcinoma
S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ...
Cell 184 (16), 4348-4371. e40, 2021
1832021
A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma
K Kadota, K Suzuki, SS Kachala, EC Zabor, CS Sima, AL Moreira, ...
Modern pathology 25 (8), 1117-1127, 2012
1742012
A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma
K Kadota, K Suzuki, C Colovos, CS Sima, VW Rusch, WD Travis, ...
Modern Pathology 25 (2), 260-271, 2012
1682012
Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma
SS Kachala, AJ Bograd, J Villena-Vargas, K Suzuki, EL Servais, K Kadota, ...
Clinical cancer research 20 (4), 1020-1028, 2014
1602014
Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma
K Kadota, K Suzuki, CS Sima, VW Rusch, PS Adusumilli, WD Travis
Journal of Thoracic Oncology 6 (5), 896-904, 2011
1472011
Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters
K Suzuki, EL Servais, NP Rizk, SB Solomon, CS Sima, BJ Park, ...
Journal of Thoracic Oncology 6 (4), 762-767, 2011
1292011
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma
K Kadota, C Colovos, K Suzuki, NP Rizk, MPS Dunphy, EC Zabor, ...
Annals of surgical oncology 19, 3598-3605, 2012
1062012
Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients
K Suzuki, K Kadota, CS Sima, M Sadelain, VW Rusch, WD Travis, ...
Cancer immunology, immunotherapy 60, 1721-1728, 2011
862011
Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
AJ Bograd, K Suzuki, E Vertes, C Colovos, EA Morales, M Sadelain, ...
Cancer Immunology, Immunotherapy 60, 1509-1527, 2011
732011
Tube cholecystostomy before cholecystectomy for the treatment of acute cholecystitis
K Suzuki, M Bower, S Cassaro, RI Patel, MS Karpeh, IM Leitman
JSLS: Journal of the Society of Laparoendoscopic Surgeons 19 (1), 2015
382015
Bronchoscopy simulation training as a tool in medical school education
M Gopal, AA Skobodzinski, HM Sterbling, SR Rao, C LaChapelle, ...
The Annals of thoracic surgery 106 (1), 280-286, 2018
372018
Age, race, and income are associated with lower screening rates at a safety net hospital
K Steiling, T Loui, S Asokan, S Nims, P Moreira, A Rebello, VR Litle, ...
The annals of thoracic surgery 109 (5), 1544-1550, 2020
362020
High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology
K Kadota, SS Kachala, J Nitadori, K Suzuki, MPS Dunphy, CS Sima, ...
Journal of Thoracic Oncology 7 (7), 1192-1197, 2012
342012
The impact of residential racial segregation on non-small cell lung cancer treatment and outcomes
CA Annesi, MR Poulson, KS Mak, U Tapan, TA Dechert, VR Litle, ...
The Annals of Thoracic Surgery 113 (4), 1291-1298, 2022
272022
Resection of primary and secondary tumors of the sternum: an analysis of prognostic variables
U Ahmad, H Yang, C Sima, DH Buitrago, RT Ripley, K Suzuki, MS Bains, ...
The Annals of thoracic surgery 100 (1), 215-222, 2015
252015
An in vivo platform for tumor biomarker assessment
EL Servais, K Suzuki, C Colovos, L Rodriguez, C Sima, M Fleisher, ...
PloS one 6 (10), e26722, 2011
252011
Redlining, structural racism, and lung cancer screening disparities
MR Poulson, KM Kenzik, S Singh, F Pavesi, K Steiling, VR Litle, K Suzuki
The Journal of Thoracic and Cardiovascular Surgery 163 (6), 1920-1930. e2, 2022
232022
The system can't perform the operation now. Try again later.
Articles 1–20